Detailed Information

Cited 13 time in webofscience Cited 18 time in scopus
Metadata Downloads

Radiotherapy for 65 patients with advanced unresectable hepatocellular carcinoma

Full metadata record
DC Field Value Language
dc.contributor.authorSeo, Yeon Seok-
dc.contributor.authorKim, Jin Nam-
dc.contributor.authorKeum, Bora-
dc.contributor.authorPark, Sanghoon-
dc.contributor.authorKwon, Yong Dae-
dc.contributor.authorKim, Yong Sik-
dc.contributor.authorJeen, Yoon Tae-
dc.contributor.authorChun, Hoon Jai-
dc.contributor.authorKim, Chul Yong-
dc.contributor.authorKim, Chang Duck-
dc.contributor.authorRyu, Ho Sang-
dc.contributor.authorUm, Soon Ho-
dc.date.available2020-11-03T10:45:57Z-
dc.date.issued2008-04-
dc.identifier.issn1007-9327-
dc.identifier.issn2219-2840-
dc.identifier.urihttps://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/17042-
dc.description.abstractAIM: To evaluate the efficacy of radiotherapy (RT) in patients with advanced unresectable hepatocellular carcinoma (HCC). METHODS: A total of 65 patients were treated with RT in the Korea University Medical Center. The median age of the patients was 60 years, and 86.2% were men. 18.5% and 81.5% of the patients were diagnosed as TNM stage M and IV-A, respectively. Treatment response was assessed 4 mo after initiation of RT. Tumor regression rate I mo after initiation of RT (TRR1m) was also assessed. Duration of survival was calculated from the initiation of RT. RESULTS: The objective treatment response was 56.9%. The 12 mo survival rate was 34.7%. Predictive factors for survival were Child-Pugh grade, alpha-fetoprotein level and treatment response. An objective response was achieved more frequently in patients with TRR1m >= 20% than in those with TRR1m < 20% (P < 0.001). CONCLUSION: RT is effective in treating advanced HCC with a tumor response rate of 56.9%. (c) 2008 WJG. All rights reserved.-
dc.format.extent7-
dc.language영어-
dc.language.isoENG-
dc.publisherBAISHIDENG PUBLISHING GROUP INC-
dc.titleRadiotherapy for 65 patients with advanced unresectable hepatocellular carcinoma-
dc.typeArticle-
dc.publisher.location미국-
dc.identifier.doi10.3748/wjg.14.2394-
dc.identifier.scopusid2-s2.0-45849118668-
dc.identifier.wosid000255252700016-
dc.identifier.bibliographicCitationWORLD JOURNAL OF GASTROENTEROLOGY, v.14, no.15, pp 2394 - 2400-
dc.citation.titleWORLD JOURNAL OF GASTROENTEROLOGY-
dc.citation.volume14-
dc.citation.number15-
dc.citation.startPage2394-
dc.citation.endPage2400-
dc.type.docTypeArticle-
dc.description.isOpenAccessY-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaGastroenterology & Hepatology-
dc.relation.journalWebOfScienceCategoryGastroenterology & Hepatology-
dc.subject.keywordPlusTRANSCATHETER ARTERIAL CHEMOEMBOLIZATION-
dc.subject.keywordPlusPRIMARY LIVER-CANCER-
dc.subject.keywordPlusLOCAL RADIOTHERAPY-
dc.subject.keywordPlusREGIONAL CHEMOTHERAPY-
dc.subject.keywordPlusHEPATIC RESECTION-
dc.subject.keywordPlusMANAGEMENT-
dc.subject.keywordPlusRADIATION-
dc.subject.keywordPlusSURVIVAL-
dc.subject.keywordPlusFLUORODEOXYURIDINE-
dc.subject.keywordPlusEXPERIENCE-
dc.subject.keywordAuthorhepatocellular carcinoma-
dc.subject.keywordAuthorradiotherapy-
dc.subject.keywordAuthortreatment response-
dc.subject.keywordAuthorsurvival-
Files in This Item
There are no files associated with this item.
Appears in
Collections
2. Clinical Science > Department of Internal Medicine > 1. Journal Articles
5. Others > Others(Medicine) > 1. Journal Articles
2. Clinical Science > Department of Radiation Oncology > 1. Journal Articles
2. Clinical Science > Department of Gastroenterology and Hepatology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Ryu, Ho Sang photo

Ryu, Ho Sang
Anam Hospital (Department of Internal Medicine, Anam Hospital)
Read more

Altmetrics

Total Views & Downloads